A drying and discharge conveyor for finished packs of cigarettes or similar, particularly in a cigarette packing machine, comprises a channel (3, 3', 7) for a row of packs (P) of cigarettes disposed one adjacent to the next, the lateral walls of this channel consisting of panels (3, 3') along which a continuous conveyor belt (1, 2) slides by steps in the direction of the axis of the channel, these...

A method for operating an ion mobility spectrometer in which an analyte sample is ionized in the spectrometer reaction chamber, and the analyte ions are permitted to flow freely from the reaction chamber into the spectrometer drift chamber. The ion current output from the spectrometer ion current detector is observed during this time. The ion flow from the reaction chamber to the drift chamber is ...

The device made of two parts is comprised of a threaded ring (10) having a recess (15) for receiving the edges (18) of the aerosol can and is also comprised of a sleeve (11) which may be fitted into the threaded ring (10) to create a force- and form-connection between the ring (10) and the aerosol can (3). The device is sealed at the sleeve (11) by a sealing lip bearing against an adapter part (2)...

In such a control valve the tightness is dependent upon the diaphragm size of the adjusting element. In order to achieve absolute tightness in the event of increased counter pressure without increasing the size of the diaphragm, it is proposed that in the closing and opening phases the adjusting element be reversibly subjectable to the intake pressure of the internal combustion engine and the atmo...

Cannula for enemas and hydrotherapy of the colon, which comprises a tubular cylindrical body in the interior of which there is arranged a removable trigger which is provided with a widening projecting from the lower end as extension of the tubular body and facilitating introduction of the cannula into the rectum, whereas a lateral introduction port which is inclined upwards emerges from the tubula...

A device for delivering an aerosol, comprising: a casing member (14), a valve stem (12), and a diaphragm (16). The diaphragm (16) contains a blend of (a) 100 parts by weight of a polyolefin random copolymer of about 80 to about 95 mole percent ethylene and a total of about 5 to about 20 mole percent of 1-butene, and (b) at least 10 parts by weight of a rubber: comprising a styrene-ethylene/butylen...

A valve for delivering a metered dose of a medicinal aerosol formulation. The valve has a filling state, a filled state, a metering state, and a dispensing state. A metering chamber (70) is formed when the device is taken from the filled state to the metering state. Means (40, 60) are provided so that, once the valve has been placed in the filled state, it can no longer be placed in the filling st...

The present invention describes conjugates of growth factors and alpha-emitting radionuclides which are suitable for detecting and treating cancer. Also provided are methods for treating cancer utilizing conjugates of growth factors and non-radioactive iodine, conjugates of growth factors and an oxyanion of a metal, and conjugates of a growth factor and a radioactive isotope.

PCT No. PCT/US92/09944 Sec. 371 Date Jul. 11, 1994 Sec. 102(e) Date Jul. 11, 1994 PCT Filed Nov. 13, 1992 PCT Pub. No. WO93/10216 PCT Pub. Date May 27, 1993There is provided by this invention a novel method of preparing Gram-negative bacterial vaccines. The method comprises providing a concentrated Gram-negative bacterial antigenic preparation,adsorbing the preparation with a mineral carrier capab...

This invention provides vaccine compositions, methods of producing same and methods for protecting porcine animals against disease associated with infection by toxigenic Pasteurella multocida. The vaccines of this invention contain effective amounts of a P. multocida bacterin with a cell-bound toxoid and, optionally, a P. multocida free toxoid.

PCT No. PCT/EP92/02704 Sec. 371 Date Jul. 15, 1994 Sec. 102(e) Date Jul. 15, 1994 PCT Filed Nov. 24, 1992 PCT Pub. No. WO93/10772 PCT Pub. Date Jun. 10, 1993The invention is represented by a transdermal medicated patch for the extended release of 17 beta -estradiol to the skin. The transdermal patch is formed by an outer covering, a matrix containing from 1% to 5% (w/w) 17 beta -estradiol, and a p...

PCT No. PCT/FR92/01105 Sec. 371 Date May 27, 1994 Sec. 102(e) Date May 27, 1994 PCT Filed Nov. 27, 1992 PCT Pub. No. WO93/10804 PCT Pub. Date Jun. 10, 1993.A black horehound extract is used to prepare a cosmetic or pharmaceutical composition, particularly a dermatological composition, for promoting skin pigmentation, preventing or delaying the growth of grey hairs, treating pigmentary disorders, r...

PCT No. PCT/GB92/02183 Sec. 371 Date May 25, 1994 Sec. 102(e) Date May 25, 1994 PCT Filed Nov. 25, 1992 PCT Pub. No. WO93/11115 PCT Pub. Date Jun. 10, 1993A class of 2-(1H)-quinolone derivatives, substituted at the 3-position by an optionally substituted aryl substituent, are selective non-competitive antagonists of NMDA receptors and/or are antagonists of AMPA receptors, and are therefore of util...

PCT No. PCT/HU92/00050 Sec. 371 Date Jan. 17, 1995 Sec. 102(e) Date Jan. 17, 1995 PCT Filed Dec. 1, 1992 PCT Pub. No. WO93/11107 PCT Pub. Date Jun. 10, 1993The invention relates to novel N-hydroxy-substituted 1,2,3,6-tetrahydropyridine and piperidine derivatives of the formula (I) wherein A, B, D, E, G, I and R are as defined in the specification, m is 0, 1 or 2, with the proviso that...

The present invention pertains to therapeutic wound healing compositions. The compositions comprise (a) pyruvate selected from the group consisting of pyruvic acid, pharmaceutically acceptable salts of pyruvic acid, and mixtures thereof, (b) an antioxidant, and (c) a mixture of saturated and unsaturated fatty acids wherein the fatty acids are those fatty acids required for repair of cellular membr...

It has been found that the growth factor PDGF, when used in combination with another growth factor such as IGF-I, acts synergistically with the other factor to promote neuronal regeneration.

Simple lactose or lactosamine related compounds which behave as ligands for the ELAM-1 and related receptors are described. These compounds are useful in the treatment of conditions characterized by excess inflammation. These compounds are of the formula wherein each R1 is independently H or lower alkyl (1-4C); R2 is H, lower alkyl (1-4C), alkylaryl or one or more additional saccharide...

The invention concerns compounds of formula (I) wherein: R<1>, R<2> and R<3> are independently hydrogen, alkyl containing 1 to 6 carbon atoms, halogen, lower alkoxy containing 1 to 6 carbon atoms, trifluoromethyl or nitro; R<6> is (a), (b) or (c) wherein R<4> and R<5> are independently hydrogen, alkyl containing 1 to 6 carbon atoms, aryl, aryl (lower alkyl) wherein aryl contains 6 to 10 carbons at...

Method of increasing activated vitamin D blood level by administering orally a 1 alpha -hydroxyprevitamin D. This previtamin D form increases vitamin D blood level without significant risk of hypercalcemia associated with other oral dosing of vitamin D forms. The 1 alpha -hydroxyprevitamin is compounded into a pharmaceutical composition in combination with a pharmaceutically acceptable excipient.